BioNTech’s cash and securities nearly equal its market value, meaning investors aren’t paying much for the Covid franchise ...

If you are wondering whether BioNTech is starting to look like value after the Covid vaccine boom faded, or if the current ...

We came across a bullish thesis on BioNTech SE on Memyselfandi007’s Substack. In this article, we will summarize the bulls’ thesis on BNTX. BioNTech SE’s share was trading at $103.80 as of March 4th.

BioNTech SE Sponsored ADR (BNTX) shares rallied 11.8% in the last trading session to close at $118. This move can be attributable to notable volume with a higher number of shares being traded than in ...

Nothing about the recent past, present, or foreseeable future seems all that compelling.

BioNTech SE – ADR (NASDAQ: BNTX) reported upbeat fourth-quarter financial results and issued FY26 sales guidance below estimates on Tuesday. BioNTech reported quarterly losses of 38 cents per share ...

BioNTech SE BNTX shares are down during Tuesday’s premarket session as the company announced plans for its co-founders to ...

Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.